Baird Financial Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.5M Buy
470,354
+33,216
+8% +$1.85M 0.04% 296
2026
Q2
$23.8M Buy
437,138
+431,355
+7,459% +$21M 0.03% 341
2026
Q1
$248K Sell
5,783
-888
-13% -$38.2K ﹤0.01% 1700
2025
Q4
$292K Sell
6,671
-771
-10% -$31.9K ﹤0.01% 1641
2025
Q3
$307K Buy
7,442
+1,575
+27% +$63.3K ﹤0.01% 1629
2025
Q2
$259K Buy
+5,867
New +$235K ﹤0.01% 1630
2024
Q3
– Sell
-44,238
Closed -$994K – 1767
2024
Q2
$994K Buy
44,238
+8,680
+24% +$193K ﹤0.01% 1172
2024
Q1
$844K Buy
35,558
+4,209
+13% +$93.6K ﹤0.01% 1209
2023
Q4
$752K Buy
+31,349
New +$682K ﹤0.01% 1222

Other funds holding EXEL

Baird Financial Group's EXEL Position: Q3 2026 in Review

Baird Financial Group increased its Exelixis (EXEL) stake by 7.6% in Q3 2026, buying an estimated $1.85M and bringing the position to 470,354 shares worth $27.5M. The position accounts for 0.04% of the portfolio, ranked #296.

Baird Financial Group first reported a position in EXEL in Q4 2023 and has held it in 9 quarters since. 769 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • Baird Financial Group held 470,354 shares of Exelixis worth $27.5M as of Q3 2026.
  • Baird Financial Group bought 33,216 Exelixis shares in Q3 2026, an estimated $1.85M.
  • Exelixis made up 0.04% of Baird Financial Group's portfolio in Q3 2026, its #296 holding.
  • Baird Financial Group first reported a position in Exelixis in Q4 2023 and has held it in 9 quarters since.
  • 769 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on Baird Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.